Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Nivolumab plus docetaxel in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: results from the phase II CheckMate 9KD trial.

Autor: Fizazi K; Department of Cancer Medicine, Gustave Roussy, University Paris Saclay, Villejuif, France. Electronic address: Karim.fizazi@gustaveroussy.fr., González Mella P; Department of Radiotherapy, Fundación Arturo López Pérez, Santiago, Chile., Castellano D; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain., Minatta JN; Department of Oncology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Rezazadeh Kalebasty A; Department of Medical Oncology, Norton Cancer Institute, Louisville, KY, USA., Shaffer D; Department of Medical Oncology, New York Oncology Hematology, Albany, NY, USA., Vázquez Limón JC; Department of Medical Oncology, Instituto Jalisciense de Cancerología, Guadalajara, Mexico., Sánchez López HM; Department of Urological Oncology, Hospital Regional de Alta Especialidad del Bajío, Guanajuato, Mexico., Armstrong AJ; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA., Horvath L; Department of Medical Oncology, Chris O'Brien Lifehouse, Camperdown, NSW, Australia., Bastos DA; Department of Oncology, Hospital Sirio-Libanes, São Paulo, Brazil., Amin NP; Department of Clinical Oncology, Bristol Myers Squibb, Princeton, NJ, USA., Li J; Department of Biostatistics, Bristol Myers Squibb, Princeton, NJ, USA., Unsal-Kacmaz K; Department of Translational Medicine, Bristol Myers Squibb, Princeton, NJ, USA., Retz M; Department of Urology, Rechts der Isar Medical Center, Technical University Munich, Munich, Germany., Saad F; Department of Urology, Centre Hospitalier de l'Université de Montréal/CHUM, Montreal, QC, Canada., Petrylak DP; Smilow Cancer Center, Yale School of Medicine, New Haven, CT, USA., Pachynski RK; Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Jan; Vol. 160, pp. 61-71. Date of Electronic Publication: 2021 Nov 18.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

LBA52 - Efficacy and safety of nivolumab in combination with docetaxel in men with metastatic castration-resistant prostate cancer in CheckMate 9KD

Autor: Fizazi, K. ¹, Gonzalez Mella, P. ², Castellano, D. ³, Minatta, J.N. ⁴, Rezazadeh Kalebasty, A. ⁵, Shaffer, D. ⁶, Vazquez Limon, J.C. ⁷, Armstrong, A.J. ⁸, Sanchez Lopez, H.M. ⁹, Sharkey, B. ¹⁰, Saci, A. ¹¹, Li, J. ¹², Wang, X. ¹², Ciprotti, M. ¹³, Sathyanarayana, P. ¹⁴, Saad, F. ¹⁵, Petrylak, D.P. ¹⁶, Retz, M.M. ¹⁷, Pachynski, R.K. ¹⁸, Drake, C. ¹⁹

Publikováno v: In Annals of Oncology October 2019 30 Supplement 5:v885-v886

EP-1218: Adjuvant radio-chemotherapy after extended or simple cholecystectomy in gallbladder cancer

Autor: González Domingo, M., Giannini Tassara, O., González Mella, P., Loredo F, E., Vasquez, M.E.

Publikováno v: In Radiotherapy and Oncology April 2015 115 Supplement 1:S659-S660